# Crimean-Congo hemorrhagic fever: serum neopterin levels and their relationship with clinical course

## TL;DR

This study explores how serum neopterin levels in patients with Crimean-Congo hemorrhagic fever correlate with disease progression and patient outcomes.

## Contribution

The study identifies serum neopterin as a potential biomarker for tracking disease progression and predicting prognosis in Crimean-Congo hemorrhagic fever.

## Key findings

- Serum neopterin levels are significantly elevated in patients with Crimean-Congo hemorrhagic fever.
- Higher neopterin levels are strongly associated with disease prognosis, including survival and mortality.
- Neopterin can serve as a biomarker to monitor disease progression and predict outcomes.

## Abstract

Crimean-Congo hemorrhagic fever is a severe viral hemorrhagic disease transmitted by ticks and characterized by fever, malaise, and hemorrhages. This research was designed to measure serum neopterin concentrations in patients with Crimean-Congo hemorrhagic fever and to assess how these levels are associated with the disease's progression.

A total of 60 patients and 25 healthy controls, monitored at the Atatürk University Infectious Diseases Clinic from March 2009 to September 2010, were enrolled in the study. Serum neopterin concentrations were determined using an ELISA method, and statistical tests were conducted to explore their association with various clinical parameters.

The results indicated a significant increase in serum neopterin levels in patients with Crimean-Congo hemorrhagic fever, and this rise was strongly linked to disease prognosis. Additionally, research has established that serum neopterin levels play a crucial role in determining patient outcomes, including survival and mortality.

This study has demonstrated that neopterin levels can be used not only to track disease progression but also as a predictor of prognosis. Future research should delve deeper into the role of this biomarker in disease management.